Slides developed by: Srihari S. Naidu, MD, FACC, FAHA, FSCAI, Chair

Slides:



Advertisements
Similar presentations
JCAHO EXPECTATIONS FOR PRIMARY STROKE CENTER
Advertisements

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning” A Report of the American College of Cardiology Foundation Task Force on Clinical.
2013 ACCF/AHA/SCAI Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures A Report of the American College of Cardiology.
Cardiogenic Shock ……………………….and Then Some SCAI C3 Summit Chicago May 12-13, 2006 “I’m Not Dead Yet” Jeffrey F. Bleakley, University of Rochester.
Chapter 3 for 12 Lead Training -Precourse-
SEPSIS KILLS program Paediatric Inpatients
Arterial Blood Gas Analysis
SEPSIS KILLS program Adult Inpatients
Severe Sepsis Initial recognition and resuscitation
Chest Pain and Cardiac Emergencies Chest Pain and Cardiac Emergencies WelcomeChest PainCertaintySimulation.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Cardiogenic Shock Diagnosis, Treatment and Guidelines Mladen I. Vidovich, MD April 5, 2007.
DUCS and RATS INTEGRIS Health.
What Type of Shock is This?
VSA 2004 Ottawa Ottawa Base HospitalDr. J. Maloney Cardiac cause Average age Gender – female 35% 34%31% other 65% 66%69%
Myocardial infarction My objectives are: Define MI or heart attack Identify people at risk Know pathophysiology of MI Know the sign & symptom Learn the.
TRANSITION SERIES Topics for the Advanced EMT CHAPTER Bleeding and Bleeding Control 36.
Introduction to Critical Care
Emergency Medical Response You Are the Emergency Medical Responder You arrive at the scene of a motor-vehicle collision, a fender bender, in which a woman.
Percutaneous Mechanical Circulatory Support Devices
False Positive ST Elevation in Patients Undergoing Direct Percutaneous Coronary Intervention David M. Larson MD, Katie M. Menssen, BS,, Scott W Sharkey.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
The (Surviving) Sepsis Campaign at Cork University Hospital
Messy Inferior STEMI J. Jeffrey Marshall, MD, FSCAI December 8, 2012.
Pulmonary Embolism and the Role of Echocardiograms in Management
EXCEL Randomized Comparison of PCI vs. CABG for Low/Intermediate Risk LM: Study Rationale Bonnie H. Weiner MD MSEC MBA FSCAI FACC FAHA Professor of Medicine.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
CASE PRESENTATION Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease.
My Best Radial Case of the Past Year ... And what I learned from it
Telemedicine To Expedite Patient’s Transfer: The Introduction of the Videophone Lowell Satler, MD Washington Hospital Center.
Sepsis 101.
Quality Improvement for Prehospital Cardiac Arrest Management
Risk Stratification of Chest Pain: Best Practices
DIRECTOR, CARDIAC CATHETERIZATION
CALS Instructor Update July 14, 2016
QUESTIONSTO BE ADDRESSED
Floriane Zeyons, MD University Hospital of Strasbourg, France
Improving Outcomes in Cardiogenic Shock
Background Information
University of Chicago Medicine
Abiomed ELAB Meeting March 3, 2017
Role of RHC during Hemodynamic Support in CGS
The Association between Prehospital Time Intervals and ST-Elevation Myocardial Infarction System Performance.
Role of ECMO in Acute Cardiogenic Shock
Use of ECGs in Assessment of Acute Posterior & Inferior MI’s
Advanced Life Support.
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
On-Site Surgical Back-up is ‘Critically’ Important for PCI!
Akshay Bagai MD, MHS St. Michael’s Hospital, Toronto, Canada
Admission Avoidance Assessment of vital signs
Windhi Dwijanarko RSU DADI KELUARGA, PURWOKERTO
Continued Scene Assessment
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization  Manesh R. Patel, MD, FACC, Steven.
Percutaneous Mechanical Circulatory Support Devices
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Landscape of STEMI Care Improvement
Objectives of patients flow map
Competency Title : Observations and The Deteriorating Patient for HCAs Competency Lead : Vikki Crickmore, Sister, Critical Care Outreach Team September.
Critical Care and Observation times
Division of Cardiovascular Diseases No relevant author disclosures
Sudden Cardiac Arrest in Intercollegiate Athletics
Q1.
Definition and Classification of Shock
How would you approach this patient?
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Evaluating the Science of Cardiogenic Shock
Presentation transcript:

A Unified Definition of Cardiogenic Shock: Introducing the SCAI SHOCK Classification System Slides developed by: Srihari S. Naidu, MD, FACC, FAHA, FSCAI, Chair David A. Baran, MD, FACC, FSCAI, FHSFA, Co-Chair

SCAI Clinical Expert Consensus Statement on the Classification of Cardiogenic Shock David A. Baran MD, FSCAI (Co‐Chair); Cindy L. Grines MD, FACC, FSCAI; Steven Bailey MD, MSCAI, FACC, FACP; Daniel Burkhoff MD, PhD; Shelley A. Hall MD, FACC, FHFSA, FAST; Timothy D. Henry MD, MSCAI; Steven M. Hollenberg MD; Navin K. Kapur MD, FSCAI; William O'Neill MD, MSCAI; Joseph P. Ornato MD, FACP, FACC, FACEP; Kelly Stelling RN; Holger Thiele MD, FESC; Sean van Diepen MD, MSc, FAHA; Srihari S. Naidu MD, FACC, FAHA, FSCAI (Chair) Baran, DA, Grines, CL, Bailey, S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv. 2019; 1– 9. https://doi.org/10.1002/ccd.28329

Key Considerations in the Diagnosis & Management of Cardiogenic Shock Is this cardiogenic shock? What is the severity? Is it predominately LV, RV, or both? What are the support options?

Traditional Definition of Cardiogenic Shock Persistent SBP < 90 mm Hg not responsive to fluid administration alone Secondary to cardiac dysfunction Associated with signs of hypoperfusion of a CI < 2.2 L/min/m2 and a PCWP > 15 mmg Hg

Shock is Variable IMPRESS Trial IABP SHOCK II Trial SBP < 90 for 30 minutes Pressors to SBP > 90 All pts intubated 90% cardiac arrest 20 minutes to ROSC 70-80% induced hypothermia Signs of Hypoperfusion (Lactate > 7-8, pH 7.1-7.2) IABP SHOCK II Trial Pulmonary Congestion Lactate > 2, Alt mental status or Urine Output < 30/hour One size does not fit all: Lack of common language has impeded the advancement of research on optimal diagnosis & management of these patients

Multidisciplinary Lexicon Interventional Cardiology Heart Failure Critical Care / Cardiology Emergency Medicine Critical Care Nursing Cardiac Surgery Experts with diverse backgrounds engaged in the creation of the SCAI SHOCK system Endorsed by AHA, ACC, STS, and SCCM

Goals of a New Shock Definition Simple and intuitive without the need for calculation Adds needed granularity in the severity of shock Suitable for rapid assessment at the bedside Allows for frequent reassessment and reclassification Can be applied to retrospective datasets or prior trials to re-examine outcomes, and future trials to better define the included population Provide new lexicon for communication between providers, including facilitating multidisciplinary communication within a hospital and between hospitals (hub and spoke model) Prognostic discriminatory potential for morbidity and mortality Easy to remember nomenclature (model INTERMACS)

Stage A: At Risk A patient who is not currently experiencing signs or symptoms of CS but is at risk for its development. These patients may include those with NSTEMI, STEMI, acute or acute on chronic CHF.

Stage B: Beginning A patient who has clinical evidence of relative hypotension or tachycardia without hypoperfusion.

Stage C: Classic A patient with hypoperfusion that requires interventions such as inotrope, pressor, or perc. MCS to restore perfusion. These patients typically have relative hypotension.

Stage D: Deteriorating Patients similar to C but are getting worse. These patients have failure to respond to initial interventions.

Stage E: Extremis Patient in cardiac arrest with ongoing CPR or ECLS placement. Alternately, being supported by multiple interventions.

Risk Modifier for Cardiac Arrest Any cardiac arrest however brief (Defib or CPR) SCAI SHOCK B(A) = A patient with relative hypotension or tachycardia without hypoperfusion who suffers a witnessed VF successfully defibrillated and remains without signs of hypoperfusion If signs of hypoperfusion develop after the arrest, this patient would be SCAI SHOCK C(A), and in need of initial efforts to improve perfusion; if those efforts do not work, the patient is now SCAI SHOCK D(A)

Case #1 57-year-old woman who had acute onset of arm pain while carrying laundry Pain not relieved after 2 hours of doing cleaning and chores and comes to the ER Blood pressure 90 / 65, pulse 101 Looks anxious but appropriate to questions Clear lungs and heart exam normal Extremities somewhat cool but 2+ pulses ECG with ST elevation in lateral leads Going to lab for urgent cath ANSWER: Stage B - Beginning

Case #1 ANSWER: Stage B “Beginning” 57-year-old woman who had acute onset of arm pain while carrying laundry Pain not relieved after 2 hours of doing cleaning and chores and comes to the ER Blood pressure 90 / 65, pulse 101 Looks anxious but appropriate to questions Clear lungs and heart exam normal Extremities somewhat cool but 2+ pulses ECG with ST elevation in lateral leads Going to lab for urgent cath ANSWER: Stage B - Beginning ANSWER: Stage B “Beginning”

Case #2 62-year-old man who is seen in the emergency room with chest pain and anterior STEMI Blood pressure 85/50, pulse 115 Cool, clammy, profusely diaphoretic No murmur, basilar crackles Extremities intact Going to Lab for cath / PCI ANSWER: Stage C - Classic

Case #2 ANSWER: Stage C “Classic” 62-year-old man who is seen in the emergency room with chest pain and anterior STEMI Blood pressure 85/50, pulse 115 Cool, clammy, profusely diaphoretic No murmur, basilar crackles Extremities intact Going to Lab for cath / PCI ANSWER: Stage C - Classic ANSWER: Stage C “Classic”

Case #3 78-year-old man brought in by EMS after collapsing at Costco Wife says last thing he told her is he was having “the big one” and clutched chest Initial rhythm VF – converted with 200 J shock Intubated at site “Stable” on wide open fluids during transport and dopamine 20 mic/kg/min Blood pressure 80/ palp, HR 130 Crackles everywhere, ? Murmur Cool everything EKG LBBB ANSWER: Stage D(A) – deteriorating with arrest modifier

Case #3 ANSWER: Stage D(A) “Deteriorating” with arrest modifier 78-year-old man brought in by EMS after collapsing at Costco Wife says last thing he told her is he was having “the big one” and clutched chest Initial rhythm VF – converted with 200 J shock Intubated at site “Stable” on wide open fluids during transport and dopamine 20 mic/kg/min Blood pressure 80/ palp, HR 130 Crackles everywhere, ? Murmur Cool everything EKG LBBB ANSWER: Stage D(A) “Deteriorating” with arrest modifier ANSWER: Stage D(A) – deteriorating with arrest modifier

Where do we go from here? Present, publish, and spread the word to the wider cardiovascular and critical care communities Validate the classification by evaluating its prognostic power and ease-of- use in databases Drive earlier recognition of shock and the more precise stage, to guide appropriate and timely escalation of care including transfer to centers more fully equipped Utilize the stages to better define prospectively the value of MCS/ECMO and other therapies Perhaps future trials looking at similar patients will finally reduce the mortality of cardiogenic shock